Merck launches HIV initiative for whole person care
Merck has launched a multi-year HIV education program in the U.S. to help people build personal networks for whole person care.
Image: Merck
Anavo Therapeutics appoints Vincent G. Brichard as Chairman
Anavo Therapeutics appoints Vincent G. Brichard as Chairman as the company advances phosphatase programs in three disease areas.
Travere Therapeutics plans CEO transition for December 2026
Travere Therapeutics plans a CEO transition, with Bradley L. Campbell set to succeed Eric Dube on December 1, 2026.
Grünenthal to acquire Stivarga from Bayer
Grünenthal will buy Bayer’s cancer drug Stivarga for up to €375 million. Closing is expected by late 2026 or early 2027.
Almirall launches film-led awareness campaign on atopic dermatitis
Almirall launches #ATOPIKER, a 60-minute awareness film designed to highlight the wider burden of atopic dermatitis.
ABDA launches new image campaign for local pharmacies
ABDA has launched a nationwide image campaign for local pharmacies and introduced a central online platform for patient information.
AbbVie named official pharmaceutical sponsor of PGA TOUR
AbbVie becomes official pharmaceutical sponsor of the PGA TOUR and launches Birdies for Brain Health to support brain health advocacy.
Tarja Stenvall named CEO of Bavarian Nordic
Bavarian Nordic appoints Tarja Stenvall as CEO. The pharma executive will take over from Paul Chaplin on October 15, 2026.
Novo Nordisk adopts Novo name in global rebrand
Novo Nordisk is adopting Novo as its everyday name in a global rebrand and updating its corporate culture with The Novo Way.
Sanofi and Cheplapharm plan mature medicines partnership
Sanofi plans to transfer 20 mature medicines and three sites to Cheplapharm, receiving a 26.4 percent equity stake in return.